BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li J, Olaleye OE, Yu X, Jia W, Yang J, Lu C, Liu S, Yu J, Duan X, Wang Y, Dong K, He R, Cheng C, Li C. High degree of pharmacokinetic compatibility exists between the five-herb medicine XueBiJing and antibiotics comedicated in sepsis care. Acta Pharm Sin B 2019;9:1035-49. [PMID: 31649852 DOI: 10.1016/j.apsb.2019.06.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Dudas B, Bagdad Y, Picard M, Perahia D, Miteva MA. Machine learning and structure-based modeling for the prediction of UDP-glucuronosyltransferase inhibition. iScience 2022;25:105290. [PMID: 36304105 DOI: 10.1016/j.isci.2022.105290] [Reference Citation Analysis]
2 Li C, Jia W, Yang J, Cheng C, Olaleye OE. Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines. Acta Pharmacol Sin. [DOI: 10.1038/s41401-022-00983-7] [Reference Citation Analysis]
3 Lu JL, Zeng XS, Zhou X, Yang JL, Ren LL, Long XY, Wang FQ, Olaleye OE, Tian NN, Zhu YX, Dong JJ, Jia WW, Li C. Molecular Basis Underlying Hepatobiliary and Renal Excretion of Phenolic Acids of Salvia miltiorrhiza Roots (Danshen). Front Pharmacol 2022;13:911982. [PMID: 35620286 DOI: 10.3389/fphar.2022.911982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hoch M, Huth F, Sato M, Sengupta T, Quinlan M, Dodd S, Kapoor S, Hourcade-Potelleret F. Pharmacokinetics of asciminib in the presence of CYP3A or P-gp inhibitors, CYP3A inducers, and acid-reducing agents. Clin Transl Sci 2022. [PMID: 35616006 DOI: 10.1111/cts.13285] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Yu X, Niu W, Wang Y, Olaleye OE, Wang J, Duan M, Yang J, He R, Chu Z, Dong K, Zhang G, Liu C, Cheng C, Li C. Novel assays for quality evaluation of XueBiJing: Quality variability of a Chinese herbal injection for sepsis management. Journal of Pharmaceutical Analysis 2022. [DOI: 10.1016/j.jpha.2022.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wu Q, Yin CH, Li Y, Cai JQ, Yang HY, Huang YY, Zheng YX, Xiong K, Yu HL, Lu AP, Wang KX, Guan DG, Chen YP. Detecting Critical Functional Ingredients Group and Mechanism of Xuebijing Injection in Treating Sepsis. Front Pharmacol 2021;12:769190. [PMID: 34938184 DOI: 10.3389/fphar.2021.769190] [Reference Citation Analysis]
7 Lan XF, Olaleye OE, Lu JL, Yang W, Du FF, Yang JL, Cheng C, Shi YH, Wang FQ, Zeng XS, Tian NN, Liao PW, Yu X, Xu F, Li YF, Wang HT, Zhang NX, Jia WW, Li C. Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule. Acta Pharmacol Sin 2021;42:2155-72. [PMID: 33931765 DOI: 10.1038/s41401-021-00651-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
8 Cheng C, Yu X. Research Progress in Chinese Herbal Medicines for Treatment of Sepsis: Pharmacological Action, Phytochemistry, and Pharmacokinetics. Int J Mol Sci 2021;22:11078. [PMID: 34681737 DOI: 10.3390/ijms222011078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
9 Zhu XB, Guo M, Zhang ZH, Sun LH, Liu L, Zhou LJ, Shan CL, Yang Y, Kan LD, Li LC. Chinese herbal injections for coronavirus disease 2019 (COVID-19): A narrative review. Integr Med Res 2021;10:100778. [PMID: 34608432 DOI: 10.1016/j.imr.2021.100778] [Reference Citation Analysis]
10 Cao L, Li Z, Ren Y, Wang M, Yang Z, Zhang W, Han X, Yao M, Sun Z, Nie S. Xuebijing Protects Against Septic Acute Liver Injury Based on Regulation of GSK-3β Pathway. Front Pharmacol 2021;12:627716. [PMID: 33995024 DOI: 10.3389/fphar.2021.627716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Pires C, Fernandes AS. Adverse Effects of Natural Products: A Brief Pre-Systematic Review. CNT 2021;2:14-20. [DOI: 10.2174/2665978601999200702163914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhou Z, Shang T, Li X, Zhu H, Qi YB, Zhao X, Chen X, Shi ZX, Pan G, Wang YF, Fan G, Gao X, Zhu Y, Feng Y. Protecting Intestinal Microenvironment Alleviates Acute Graft-Versus-Host Disease. Front Physiol 2020;11:608279. [PMID: 33643058 DOI: 10.3389/fphys.2020.608279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Auxtero MD, Chalante S, Abade MR, Jorge R, Fernandes AI. Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction. Pharmaceutics 2021;13:124. [PMID: 33478035 DOI: 10.3390/pharmaceutics13010124] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Shang T, Yu Q, Ren T, Wang XT, Zhu H, Gao JM, Pan G, Gao X, Zhu Y, Feng Y, Li MC. Xuebijing Injection Maintains GRP78 Expression to Prevent Candida albicans-Induced Epithelial Death in the Kidney. Front Pharmacol 2019;10:1416. [PMID: 31969817 DOI: 10.3389/fphar.2019.01416] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Wu Q, Xu Y, Peng W, Feng F, Wang Z, Han D, Gu C, Zhou X. Advances in treatment of COVID-19. Integrat Respir Med 2020;1:1. [DOI: 10.1051/irm/2020001] [Reference Citation Analysis]